Get App Open
In App
Lending
Lending
Open App
you are here:

ITI Pharma & Healthcare Fund - Regular Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
  • NAV
    : ₹ 16.5012 0.46%
    (as on 17th October, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 98.53% investment in domestic equities of which 29.12% is in Large Cap stocks, 20.28% is in Mid Cap stocks, 16.15% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    NIFTY Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 17th October, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 10-Oct-25 10050.70 0.51% - 0.84% 143/239
1 Month 17-Sep-25 10049.10 0.49% - 0.12% 84/237
3 Month 17-Jul-25 9796.80 -2.03% - 1.18% 201/229
6 Month 17-Apr-25 10466.30 4.66% - 10.67% 209/224
YTD 01-Jan-25 9411.50 -5.88% - 3.73% 197/213
1 Year 17-Oct-24 9737.20 -2.63% -2.63% 0.26% 128/196
2 Year 17-Oct-23 14915.80 49.16% 22.10% 18.53% 37/152
3 Year 17-Oct-22 17491.60 74.92% 20.47% 20.02% 53/127
Since Inception 08-Nov-21 16501.20 65.01% 13.55% 12.71% 115/217

SIP Returns (NAV as on 17th October, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 17-Oct-24 12000 12242 2.02 % 3.75 %
2 Year 17-Oct-23 24000 27070.27 12.79 % 12.03 %
3 Year 17-Oct-22 36000 47513.09 31.98 % 18.86 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 30th Sep,2025)

Equity Holding : 98.53% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 98.53%
No of Stocks : 43 (Category Avg - 44.42) | Large Cap Investments : 29.12%| Mid Cap Investments : 20.28% | Small Cap Investments : 16.15% | Other : 32.98%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 240.6 10.62% 0.02% 16.72% (Apr 2025) 10.6% (Aug 2025) 1.51 L 0.00
Divis Laboratories Ltd. Pharmaceuticals 176.4 7.79% -0.59% 9.12% (May 2025) 4.76% (Oct 2024) 31.00 k 0.00
Apollo Hospitals Enterprises Ltd. Hospital 131.7 5.81% -0.15% 5.96% (Aug 2025) 4.75% (Nov 2024) 17.78 k 0.00
Max Healthcare Institute Ltd. Hospital 129 5.70% -0.19% 6.12% (Jun 2025) 2.15% (Oct 2024) 1.16 L 0.00
Suven Pharmaceuticals Ltd. Pharmaceuticals 114.5 5.06% 0.75% 6.06% (Feb 2025) 4.31% (Aug 2025) 1.30 L 19.13 k
Torrent Pharmaceuticals Ltd. Pharmaceuticals 104 4.59% 0.06% 4.59% (Sep 2025) 1.95% (Oct 2024) 28.86 k 0.00
Fortis Healthcare Ltd. Hospital 93.5 4.13% 0.26% 4.13% (Sep 2025) 1.35% (Oct 2024) 96.36 k 0.00
Aurobindo Pharma Ltd. Pharmaceuticals 82 3.62% 0.19% 4.94% (Dec 2024) 3.43% (Aug 2025) 75.61 k 0.00
Aster DM Healthcare Ltd. Hospital 78 3.45% 0.15% 3.45% (Sep 2025) 2.09% (Oct 2024) 1.24 L 0.00
Lupin Ltd. Pharmaceuticals 68.9 3.04% 0.03% 6.72% (Oct 2024) 3.01% (Aug 2025) 36.05 k 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
Net Receivables Net Receivables 1.47%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)

  • Standard Deviation

    Low volatility
    12.04vs12.57
    Category Avg
  • Beta

    Low volatility
    0.85vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.04vs1.01
    Category Avg
  • Treynor's Ratio

    Poor risk adjusted returns
    0.15vs0.18
    Category Avg
  • Jensen's Alpha

    Poor risk adjusted returns
    0.55vs3.66
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 406.67 1.64 22.45 80.15 39.37 39.86
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 266.19 0.03 7.52 25.09 23.94 19.64
Franklin Asian Equity Fund - Growth NA 279.13 1.98 10.78 26.48 17.44 15.90
Nippon India Japan Equity Fund - Growth NA 289.73 -1.11 10.80 17.31 16.59 19.11
DSP Banking & Financial Services Fund - Regular Plan - Growth NA 1419.62 3.43 2.82 9.76 15.66 0.00
SBI Banking & Financial Services Fund - Regular Plan - Growth NA 8693.07 3.13 2.45 10.22 15.56 20.00
HDFC Transportation and Logistics Fund - Regular Plan - Growth NA 1651.55 -0.73 10.48 30.58 14.69 0.00
Motilal Oswal Business Cycle Fund - Regular Plan - Growth NA 1984.52 -1.74 2.61 12.61 14.58 0.00
ITI Banking and Financial Services Fund - Regular Plan - Growth NA 311.03 4.24 2.02 6.75 14.32 14.62
WhiteOak Capital Banking & Financial Services Fund - Regular Plan - Growth NA 483.64 1.78 1.72 7.71 13.14 0.00

More Funds from ITI Asset Management Ltd.

Out of 19 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 1 is/are ranked 4 * , 2 is/are ranked 3 * , 1 is/are ranked 2 * , 1 is/are ranked 1 * , and 13 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
ITI Small Cap Fund - Regular Plan - Growth 5 2666.63 -0.60 -2.80 9.94 -3.46 26.25
ITI Multi Cap Fund - Regular Plan - Growth 3 1267.93 -0.39 -0.59 11.89 -4.46 20.04
ITI Mid Cap Fund - Regular Plan - Growth 3 1227.33 1.24 0.67 11.64 -3.41 23.19
ITI Flexi Cap Fund - Regular Plan - Growth NA 1202.95 0.18 0.12 12.17 -3.44 0.00
ITI Large & Mid Cap Fund - Regular Plan - Growth NA 847.45 0.38 -1.48 10.27 -3.24 0.00
ITI Focused Fund - Regular Plan - Growth NA 536.47 1.49 0.58 12.20 1.57 0.00
ITI Large Cap Fund - Regular Plan - Growth 2 516.80 0.60 -0.62 7.73 -1.34 15.12
ITI ELSS Tax Saver Fund - Growth 4 422.77 -0.16 -1.97 10.48 -4.16 21.24
ITI Balanced Advantage Fund - Growth NA 396.82 0.19 0.89 6.55 1.79 12.54
ITI Value Fund - Growth 1 330.92 1.10 -1.62 8.96 -4.27 19.36

Forum

+ See More